The Ethics of Elective Growth Hormone Therapy in Children

with Idiopathic Short Stature


Kevin Leslie Kecskemeti and Samuel Reis-Dennis


In this article, we analyze the ethics of elective growth hormone (GH) therapy in children with idiopathic short stature (ISS). We discuss recent clinical research regarding the efficacy, side-effects, and risks of GH therapy, and argue that GH therapy is ethically unjustifiable for most children with ISS.



Read the full text


Institutional Subscribers


Individual Subscribers


Nonsubscriberspurchase a .pdf of the article